Investor Consensus — Stock Market Data, Analyst Ratings, Price Targets & Investor Sentiment Polls

Sector Performance Snapshot 2026-08-15
Industry Performance Snapshot 2026-08-15
Top Crypto View All →
Symbol Name Exchange ICO Date Circulating Supply Total Supply
Latest Price Targets
Date Symbol News Price Target Price When Posted
Most Active Stock Companies
Full List
Symbol Name Price Change %Chg
Market Heatmap

S&P 500 by sector

View Full
Loading...
PRICE
MKT CAP
VOLUME
Top Gainers
Full List
Symbol Price Change %Chg
Biggest Decliners
Full List
Symbol Price Change %Chg

Latest Articles

Latest News

Stock Market Holidays
Day Date
Earning Calendar
IPO Calendar

No upcoming IPO dates available.

Dividend Calendar

No upcoming dividend dates available.

Stock Splits Calendar

No upcoming stock splits available.

Upgrades & Downgrades

No recent analyst grade changes available.

FMP Articles
Articles
Market Movers For 1/5/2024

Market Movers For 1/5/2024

The Investor Consensus 52-Week High Watchlist for 12/28/2023

The Investor Consensus 52-Week High Watchlist for 12/28/2023

Pre-market Gainers Report for 12/29/2023

Pre-market Gainers Report for 12/29/2023

Five Day Gainers as of 12/29/2023

Five Day Gainers as of 12/29/2023

What's Behind the 197% Surge in Canaan Inc. (Nasdaq: CAN)?

What's Behind the 197% Surge in Canaan Inc. (Nasdaq: CAN)?

Analysts Predict Sky-High Future: Rocket Lab (RKLB) Gets $10 Target

Analysts Predict Sky-High Future: Rocket Lab (RKLB) Gets $10 Target

Sphere 3D Corp. (Nasdaq: ANY) Surges 468% in a Month: What's Behind the Meteoric Rise?

Sphere 3D Corp. (Nasdaq: ANY) Surges 468% in a Month: What's Behind the Meteoric Rise?

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) Surges 278% on Positive Phase 2 Trial Results for EYP-1901 in Wet AMD

EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) Surges 278% on Positive Phase 2 Trial Results for EYP-1901 in Wet AMD